Advertisement


Sun Pharmaceutical Industries
Business  /  Published 31.07.21

Sun Pharma net at Rs 1444cr

Drug major Sun Pharmaceutical Industries on Friday reported a consolidated net profit of Rs 1,444.17 crore for the June 2021 quarter, mainly on account of robust sales across markets. The company had ...
By Our Bureau in Calcutta, Mumbai

Business  /  Published 28.05.21

Sun Pharma net profit jumps two-fold

Drug major Sun Pharmaceutical Industries on Thursday reported an over two-fold jump in consolidated net profit at Rs 894.15 crore for the quarter ended March 2021, mainly on account of a robust perfor...
By Our Bureau in New Delhi

Business  /  Published 12.02.21

Sun Pharma settles whistleblower suit

Sun Pharmaceutical Industries Ltd and its founder Dilip Shanghvi have settled a whistleblower complaint with the Securities and Exchange Board of India (Sebi) alleging diversion of funds through the c...
By Our Special Correspondent in Mumbai

Business  /  Published 22.01.19

Sun Pharma tries to limit damage

...
By Our Bureau in Mumbai

Business  /  Published 30.03.20

Curbs on Sun Pharma

The shares of Sun Pharmaceutical Industries ended lower on the bourses on Monday after the company said that the US drug regulator may not give the green signal for the export of new products from its...
By Our Special Correspondent in Mumbai

Business  /  Published 13.03.20

Sun Pharma to consider buyback

Shares of Sun Pharmaceutical Industries rallied over 8 per cent a day after the company informed that its board will be meeting next week to discuss a proposal for buyback of shares.On the BSE, the Su...
By Our Special Correspondent in Mumbai

Business  /  Published 03.12.18

Sun Pharma bid to limit damage

Dilip Shanghvi, the founder and managing director of Sun Pharmaceutical Industries, on Monday indicated the company was open to taking a relook at some of the earlier transactions or decisions in the ...
By Our Special Correspondent in Mumbai

Business  /  Published 17.03.20

Sun Pharmaceutical buyback of Rs 1700 crore

Drug major Sun Pharmaceutical Industries on Tuesday said its board has approved a Rs 1,700-crore share buyback offer at a maximum price of Rs 425 per share.The board of directors, at its meeting held ...
By Our Special Correspondent in New Delhi


Advertisement

Download our latest App

to get update on the go...


Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.